MVM Partners, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 14, 2024), MVM Partners, LLC reported 3 stock positions worth $167.1 million. Its top holding was Paragon 28 (FNA) at 80.2% of the portfolio, followed by Optinose (12.7%) and Mdxhealth (MDXH, 7.0%). Its holdings were unchanged from Q4 2023.
- Most Recent 13F
- Q2 2026
- Location
- BOSTON, MA
- CIK
- 0001947083
- Portfolio Value
- $167.1M (Q1 2024)
- SEC Filing
- 0000950159-24-000155 ↗ filed May 14, 2024
Holdings Value
Holdings 3 stocks · $167.1M
| FNA Paragon 28 Inc. | 80.25% | 10,886,145 | $134.1M | No change |
| OPTINOSE INC | 12.71% | 14,605,263 | $21.3M | No change |
| MDXH Mdxhealth | 7.04% | 4,550,457 | $11.8M | No change |
Portfolio Sells Q4 2023 → Q1 2024
| None this quarter. | |||
Portfolio Buys Q4 2023 → Q1 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 1 | $1.9M | MDXH |
| Q1 2026 | 1 | $10.8M | MDXH |
| Q4 2025 | 1 | $16.8M | MDXH |
| Q3 2025 | 1 | $21.8M | MDXH |
| Q2 2025 | 1 | $10.3M | MDXH |
| Q1 2025 | 3 | $78.9M | FNA, OPTINOSE INC, MDXH |
| Q4 2024 | 3 | $124.4M | FNA, MDXH, OPTINOSE INC |
| Q3 2024 | 3 | $91.7M | FNA, MDXH, OPTINOSE INC |
| Q2 2024 | 3 | $99.9M | FNA, OPTINOSE INC, MDXH |
| Q1 2024 | 3 | $167.1M | FNA, OPTINOSE INC, MDXH |